Disappointment and/or a glimmer of hope? - When biochemical efficacy does not translate into (primary) clinical benefit
Rare Disease and Orphan Drugs Journal · 30.10.2026 · 5 (4)
DOI: 10.20517/rdodj.2026.32 ↗Kurz gefasst
Fachartikel in der Zeitschrift Rare Disease and Orphan Drugs Journal, online erschienen am 30.10.2026. Verfasst von Christopher Paschen und 3 weiteren Autor:innen. Die Arbeit nennt 19 Literaturangaben.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Zitieren
APA
Paschen, C., Allmer, D. M., Schmidt, A., & Sunder-Plassmann, G. (2026). Disappointment and/or a glimmer of hope? - When biochemical efficacy does not translate into (primary) clinical benefit. Rare Disease and Orphan Drugs Journal, 5(4). https://doi.org/10.20517/rdodj.2026.32
Vancouver
Paschen C, Allmer DM, Schmidt A, Sunder-Plassmann G. Disappointment and/or a glimmer of hope? - When biochemical efficacy does not translate into (primary) clinical benefit. Rare Disease and Orphan Drugs Journal. 2026;5(4). doi:10.20517/rdodj.2026.32
BibTeX
@article{Paschen2026,
author = {Paschen, Christopher and Allmer, Daniela Maria and Schmidt, Alice and Sunder-Plassmann, Gere},
title = {Disappointment and/or a glimmer of hope? - When biochemical efficacy does not translate into (primary) clinical benefit},
journal = {Rare Disease and Orphan Drugs Journal},
year = {2026},
volume = {5},
number = {4},
doi = {10.20517/rdodj.2026.32}
}
EUVIMED